UpdatesPress Release
Caplin Point's subsidiary, Caplin Steriles, secured approval for Desmopressin Acetate Injection.
Caplin Point Laboratories LimitedCAPLIPOINT · Filed with the exchange
This generic drug targets a US market with annual sales of approx. 215.8 Cr ($26 million), enhancing future revenue potential.
No comments yet. Be the first.